Medtronic (NYSE: MDT) reported Q2 EPS of $1.26, $0.01 better than the analyst estimate of $1.25. Revenue for the quarter came in at $8.4 billion versus the consensus estimate of $8.28 billion.

GUIDANCE:

Medtronic sees FY2025 EPS of $5.44-$5.50, versus the consensus of $5.45.

For earnings history and earnings-related data on Medtronic (MDT) click here.